Physician profile
Clara W Dougherty
NPI 1609987619
$4,377.61
in general payments reported to CMS, 2019-2025
35 companies · $1,181 in 2025
The $1,181 reported for 2025 was more than what 83% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $651 · 2022: $1,052 · 2023: $1,009 · 2024: $485 · 2025: $1,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,674.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $687.18 | 2021-2025 | Erleada, Akeega |
| Abbvie INC. | $537.55 | 2021-2025 | |
| Teleflex LLC | $483.40 | 2021-2025 | Urolift |
| Coloplast Corp | $453.37 | 2021-2025 | Speedicath |
| Urogen Pharma, INC. | $241.67 | 2022-2025 | Jelmyto |
| Medtronic, INC. | $236.10 | 2023-2025 | Interstim |
| Sumitomo Pharma America, INC. | $222.83 | 2024-2025 | Gemtesa, Orgovyx |
| Janssen Scientific Affairs, LLC | $193.19 | 2022-2023 | Erleada |
| Rochester Medical Corporation | $170.84 | 2021-2022 | |
| Eisai INC. | $115.02 | 2025 | |
| Convatec INC. | $110.75 | 2021-2023 | |
| Pfizer INC. | $104.41 | 2022-2024 | |
| Astellas Pharma US INC | $92.96 | 2021-2022 | |
| Hollister Incorporated | $88.63 | 2021-2025 | Vapro |
| Myriad Genetic Laboratories, INC. | $88.02 | 2021-2023 | Prolaris |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $49.89 | 2023 | Oxlumo |
| Ferring Pharmaceuticals INC. | $47.69 | 2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $43.16 | 2022-2025 | |
| Immunitybio, INC. | $39.30 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $36.58 | 2023-2025 | Bard Urinary Drainage Bag |
| Sagent Pharmaceuticals | $33.35 | 2021-2022 | |
| Blue Earth Diagnostics | $32.99 | 2023 | |
| Abc Home Medical Supply, INC. | $30.23 | 2024-2025 | |
| Angiodynamics, INC. | $26.22 | 2023 | Nanoknife |
| Tolmar Pharmaceuticals, INC. | $24.71 | 2022 | |
| Endo USA, INC. | $22.59 | 2025 | Xiaflex |
| Palette Life Sciences, INC. | $22.49 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $21.24 | 2022 | |
| Olympus America INC. | $20.45 | 2021 | |
| Myovant Sciences INC. | $19.97 | 2022 | |
| Halozyme INC | $18.51 | 2023 | |
| Urovant Sciences INC | $16.15 | 2022 | |
| Intuitive Surgical, INC. | $16.00 | 2023 | Da Vinci Surgical System |
| Photocure INC | $15.13 | 2024 | Cysview |
| Procept Biorobotics Corporation | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clara Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.